1. Background
2. Objectives
3. Methods
4. Results
| Groups | Initial Body Weight (g) | Final Body Weight (g) | Behavioral Changes | Unexpected Mortality |
|---|---|---|---|---|
| Control | 210 ± 12 | 315 ± 15 | Normal | None |
| Wi-Fi | 212 ± 11 | 298 ± 18 (P < 0.05 vs. control) b | Mild lethargy | None |
| Q10 | 209 ± 13 | 320 ± 14 | Normal | None |
| Wi-Fi + Q10 | 211 ± 12 | 310 ± 16 | Slight restlessness | None |
| Vehicle | 210 ± 10 | 312 ± 15 | Normal | None |
a Values are expressed as mean ± standard deviation (SD).
b One-way ANOVA followed by Tukey’s post-hoc test. P < 0.05 compared with control; η2 values reported in text
| Groups | Sperm Count (× 106/mL) | Motility (%) | Viability (%) | Normal Morphology (%) |
|---|---|---|---|---|
| Control | 85 ± 6 | 78 ± 5 | 82 ± 4 | 80 ± 5 |
| Wi-Fi | 62 ± 7 (P < 0.05 vs. control) b | 55 ± 6 (P < 0.05) b | 58 ± 5 (P < 0.05) b | 60 ± 6 (P < 0.05) b |
| Q10 | 90 ± 5 (P < 0.05 vs. Wi-Fi) | 82 ± 4 (P < 0.05) | 85 ± 3 (P < 0.05) | 83 ± 4 (P < 0.05) |
| Wi-Fi + Q10 | 75 ± 6 (P < 0.05 vs. Wi-Fi) | 70 ± 5 (P < 0.05) | 72 ± 4 (P < 0.05) | 73 ± 5 (P < 0.05) |
| Vehicle | 84 ± 6 | 77 ± 5 | 81 ± 4 | 79 ± 5 |
a Values are expressed as mean ± standard deviation (SD).
b Effect size (η2 = 0.42 for sperm count) is reported.
| Groups | Serum Testosterone (ng/mL) |
|---|---|
| Control | 4.8 ± 0.4 |
| Wi-Fi | 3.1 ± 0.3 (P < 0.05 vs. control) b |
| Q10 | 5.2 ± 0.5 (P < 0.05 vs. Wi-Fi) |
| Wi-Fi + Q10 | 4.2 ± 0.4 (P < 0.05 vs. Wi-Fi) |
| Vehicle | 4.7 ± 0.4 |
a Values are expressed as mean ± standard deviation (SD).
b Effect size (η2 = 0.38) is reported.
| Groups | Seminiferous Tubule Integrity | Leydig Cell Morphology | Interstitial Inflammation |
|---|---|---|---|
| Control | 0.2 ± 0.1 | 0.1 ± 0.1 | 0.1 ± 0.1 |
| Wi-Fi | 2.5 ± 0.3 (P < 0.05 vs. control) b | 2.2 ± 0.4 (P < 0.05) b | 2.0 ± 0.3 (P < 0.05) b |
| Q10 | 0.3 ± 0.1 (P < 0.05 vs. Wi-Fi) | 0.2 ± 0.1 (P < 0.05) | 0.2 ± 0.1 (P < 0.05) |
| Wi-Fi + Q10 | 1.2 ± 0.2 (P < 0.05 vs. Wi-Fi) | 1.0 ± 0.2 (P < 0.05) | 1.1 ± 0.2 (P < 0.05) |
| Vehicle | 0.3 ± 0.1 | 0.2 ± 0.1 | 0.2 ± 0.1 |
a Values are expressed as mean ± standard deviation (SD).
b Histopathology scores analyzed with Kruskal-Wallis test (η2 = 0.45)
| Groups | Tubular Damage | Interstitial Inflammation | Glomerular Changes |
|---|---|---|---|
| Control | 0.2 ± 0.1 | 0.1 ± 0.1 | 0.1 ± 0.1 |
| Wi-Fi | 2.3 ± 0.3 (P < 0.05 vs. control) b | 2.0 ± 0.3 (P < 0.05) b | 1.5 ± 0.2 (P < 0.05) b |
| Q10 | 0.3 ± 0.1 (P < 0.05 vs. Wi-Fi) | 0.2 ± 0.1 (P < 0.05) | 0.2 ± 0.1 (P < 0.05) |
| Wi-Fi + Q10 | 1.1 ± 0.2 (P < 0.05 vs. Wi-Fi) | 1.0 ± 0.2 (P < 0.05) | 0.8 ± 0.2 (P < 0.05) |
| Vehicle | 0.3 ± 0.1 | 0.2 ± 0.1 | 0.2 ± 0.1 |
a Values are expressed as mean ± standard deviation (SD).
b Histopathology scores analyzed with Kruskal-Wallis test (η2 = 0.41).
Antioxidant enzyme activities [superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx)] in testes and kidneys across experimental groups (data are presented as mean ± standard deviation (SD); n = 8; one-way ANOVA followed by Tukey’s post-hoc test; P < 0.05 compared with control; η2 = 0.41).

![Antioxidant enzyme activities [superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx)] in testes and kidneys across experimental groups (data are presented as mean ± standard deviation (SD); n = 8; one-way ANOVA followed by Tukey’s post-hoc test; P < 0.05 compared with control; η<sup>2</sup> = 0.41). Antioxidant enzyme activities [superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx)] in testes and kidneys across experimental groups (data are presented as mean ± standard deviation (SD); n = 8; one-way ANOVA followed by Tukey’s post-hoc test; P < 0.05 compared with control; η<sup>2</sup> = 0.41).](https://brieflands.com/journals/jjnpp/articles/169131/figures/jjnpp-21-1-169131-i002-preview.webp)